N19-908S022 Zolpidem Clinical BPCA Clinical BPCA · zolpidem was unacceptably high (7.4%) in...
54
N19-908S022 Zolpidem Clinical BPCA Clinical BPCA · zolpidem was unacceptably high (7.4%) in comparison with the incidence in patients treated with placebo (0%); for comparison, in